Construction and validation of an educational technology on human papillomavirus vaccine for adolescents

Gisele De Castro Varela Cruz,Mardênia Gomes Ferreira Vasconcelos,Sâmia Jardelle Costa De Freitas Maniva,Rhanna Emanuela Fontenele Lima De Carvalho

doi:10.1590/2177-9465-ean-2019-0050

Abstract

ABSTRACT Objective: To construct and validate a comic-type educational technology on the human papillomavirus vaccine. Methods: A methodological study developed based on the manuals, informative notes of the Ministry of Health and with the suggestions of the target audience. Content validation was performed with 11 expert judges and the validation of appearance, with 32 adolescents. For the judges, the Content Validity Index was used and for the target audience the proportion of agreement was considered. Results: The comic book obtained a content validation index total of 0.95, a validation index considered adequate. It was identified a concordance greater than 0.80 in the validation of appearance with the target public, indicating an excellent degree of agreement. Conclusion: The technology was considered valid by the judges and the target audience, and can be used as an educational tool to guide the practice in the acceptability scenario of the vaccine. Implications for practice: The technology may contribute to the stimulation of adhesion to the human papillomavirus vaccine, since, in Brazil, the rates of adhesion to this vaccine are still low.

Highlights

The Human Papillomavirus (HPV) is a virus that is related to various types of cancers
Implications for practice: The technology may contribute to the stimulation of adhesion to the human papillomavirus vaccine, since, in Brazil, the rates of adhesion to this vaccine are still low
The human papillomavirus vaccine or quadrivalent, which involves protection against four types of viruses (6, 11, 16, 18), emerges as a public health strategy in the search to prevent malignant neoplasms related to the virus, collaborating in reducing the incidence, prevalence and mortality of the different types of cancers[2]

Summary

Introduction

The Human Papillomavirus (HPV) is a virus that is related to various types of cancers. The virus is responsible for up to 70.0% of cases of cervical cancer in the world, as well as 90.0% of cases of anus cancer, up to 60.0% of cases of vaginal cancer and up to 50% of cases of vulvar cancer[2]. In this context, the human papillomavirus vaccine or quadrivalent, which involves protection against four types of viruses (6, 11, 16, 18), emerges as a public health strategy in the search to prevent malignant neoplasms related to the virus, collaborating in reducing the incidence, prevalence and mortality of the different types of cancers[2]. In 2017, girls in the age group of 09 to 14 years and boys of 11 to 14 years corresponded to the target audience[2,3]

Methods

Results

Discussion

Conclusion